
    
      Multi-center study of specimens from subjects presenting for flow cytometry immunophenotyping
      as part of their standard of care for hematological diseases work-up. Residual specimens will
      be tested using the ClearLLab Panels to determine the presence or absence of an abnormal
      phenotype and compare results to clinical impression (hematological malignancy or
      non-malignancy).
    
  